BioSpace News Archive

Drug Development

Sedana Medical receives IND approval for US trial

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the company has received Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA) to initiate phase III pivotal clinical trials with its Sedaconda products in the United States.

December 23, 2021
·
2 min read
Business

Aeterna Zentaris Appoints Giuliano La Fratta as Chief Financial Officer

Aeterna Zentaris Inc., a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, announced the appointment of Giuliano La Fratta as Senior Vice President, Chief Financial Officer.

December 23, 2021
·
5 min read
Genetown

Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences

Sosei Group Corporation announces that in connection with the Collaboration and License Agreement with Neurocrine Biosciences, Inc. announced 22 November 2021, the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 expired on 22 December 2021.

December 23, 2021
·
3 min read
BioCapital

Novavax and SK bioscience Expand Manufacturing Agreement

Novavax, Inc. and SK bioscience, Co. Limited announced the expansion of the companies’ collaboration and license agreements for NVX-CoV2373, Novavax’ recombinant nanoparticle protein-based COVID-19 vaccine.

December 23, 2021
·
8 min read
The Medical Products Agency in Sweden will be reference member state for Moberg Pharma’s European registration application

The Medical Products Agency in Sweden has agreed to be reference member state for Moberg Pharma AB’s registration application for MOB-015.

December 23, 2021
·
2 min read
eQcell Inc. announces completion of a capital raise

eQcell Inc., Canada’s first company to be authorized by Health Canada for the clinical testing of mesenchymal stromal cells (MSCs) for the treatment of equine arthritis, is pleased to announce the receipt of an investment in common equity of C$4.8 million.

December 23, 2021
·
2 min read
Policy

Philips provides update on the test and research program in connection with the CPAP, BiPAP and Mechanical Ventilator recall notification*

On June 14, 2021, Royal Philips’ subsidiary, Philips Respironics, initiated a voluntary recall notification* for certain sleep and respiratory care products to address potential health risks related to the polyester-based polyurethane sound abatement foam in these devices.

December 23, 2021
·
4 min read
Philips and IJsselland Hospital sign long-term technology partnership

Royal Philips, a global leader in health technology, announced it has signed a 12-year strategic partnership with IJsselland Hospital.

December 23, 2021
·
2 min read
LumiraDx COVID-19 & Flu A/B Rapid Antigen Test Achieves CE Marking

LumiraDx, a next-generation point of care diagnostics company, announced its SARS-CoV-2 & Flu A/B Antigen Test has achieved CE Marking.

December 23, 2021
·
5 min read
Business

Empower Clinics Hires Chief Financial Officer With NASDAQ Healthcare Experience

EMPOWER CLINICS INC. announced today that Jennifer Archibald has been appointed Chief Financial Officer (“CFO”) of Empower.

December 23, 2021
·
6 min read